Avidity Partners Management as of June 30, 2020
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 57 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 9.7 | $152M | 1.5M | 98.18 | |
| Regeneron Pharmaceuticals (REGN) | 5.3 | $82M | 132k | 623.65 | |
| Biohaven Pharmaceutical Holding | 5.2 | $81M | 1.1M | 73.11 | |
| Baxter International (BAX) | 4.4 | $69M | 801k | 86.10 | |
| Immunomedics | 4.3 | $68M | 1.9M | 35.44 | |
| Exelixis (EXEL) | 4.1 | $64M | 2.7M | 23.74 | |
| Alexion Pharmaceuticals | 3.7 | $57M | 508k | 112.24 | |
| Hologic (HOLX) | 3.0 | $47M | 817k | 57.00 | |
| Seattle Genetics | 2.7 | $43M | 251k | 169.92 | |
| Aurinia Pharmaceuticals (AUPH) | 2.6 | $40M | 2.5M | 16.25 | |
| Momenta Pharmaceuticals | 2.5 | $38M | 1.2M | 33.27 | |
| Chemocentryx | 2.4 | $37M | 646k | 57.54 | |
| Arvinas Ord (ARVN) | 2.3 | $36M | 1.1M | 33.54 | |
| Axsome Therapeutics (AXSM) | 2.1 | $33M | 405k | 82.28 | |
| Kadmon Hldgs | 2.1 | $33M | 6.4M | 5.12 | |
| Principia Biopharma | 2.1 | $33M | 549k | 59.79 | |
| Zentalis Pharmaceuticals (ZNTL) | 2.1 | $32M | 675k | 48.02 | |
| Horizon Therapeutics Pub SHS | 1.9 | $30M | 536k | 55.58 | |
| Esperion Therapeutics (ESPR) | 1.8 | $29M | 560k | 51.31 | |
| Avantor (AVTR) | 1.8 | $27M | 1.6M | 17.00 | |
| Vir Biotechnology (VIR) | 1.6 | $25M | 621k | 40.97 | |
| Mersana Therapeutics (MRSN) | 1.6 | $25M | 1.1M | 23.40 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.5 | $24M | 2.7M | 8.87 | |
| Syndax Pharmaceuticals (SNDX) | 1.5 | $23M | 1.5M | 14.82 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $23M | 185k | 122.00 | |
| Syneos Health Cl A | 1.4 | $21M | 367k | 58.25 | |
| Bristol-myers Squibb Right 99/99/9999 | 1.3 | $21M | 5.8M | 3.58 | |
| Bioxcel Therapeutics (BTAI) | 1.3 | $21M | 388k | 53.01 | |
| Iovance Biotherapeutics (IOVA) | 1.3 | $20M | 739k | 27.45 | |
| Crispr Therapeutics Namen Akt (CRSP) | 1.3 | $20M | 274k | 73.49 | |
| Harpoon Therapeutics | 1.3 | $20M | 1.2M | 16.60 | |
| McKesson Corporation (MCK) | 1.3 | $20M | 128k | 153.42 | |
| Ideaya Biosciences (IDYA) | 1.2 | $19M | 1.3M | 14.21 | |
| Coherus Biosciences (CHRS) | 1.2 | $18M | 1.0M | 17.86 | |
| Editas Medicine (EDIT) | 1.1 | $18M | 600k | 29.58 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 1.1 | $18M | 119k | 147.90 | |
| Astrazeneca Sponsored Adr (AZN) | 1.1 | $17M | 326k | 52.89 | |
| Alector (ALEC) | 1.1 | $17M | 686k | 24.44 | |
| Medtronic SHS (MDT) | 1.0 | $16M | 174k | 91.70 | |
| Prevail Therapeutics Ord | 1.0 | $15M | 1.0M | 14.90 | |
| Arcus Biosciences Incorporated (RCUS) | 0.9 | $15M | 589k | 24.74 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.9 | $14M | 1.4M | 10.01 | |
| Anika Therapeutics (ANIK) | 0.9 | $14M | 363k | 37.73 | |
| Royalty Pharma Shs Cl A (RPRX) | 0.6 | $9.7M | 200k | 48.55 | |
| Surface Oncology | 0.6 | $9.7M | 1.5M | 6.56 | |
| Deciphera Pharmaceuticals (DCPH) | 0.6 | $9.3M | 156k | 59.72 | |
| Intellia Therapeutics (NTLA) | 0.6 | $8.8M | 418k | 21.02 | |
| Verastem | 0.5 | $7.6M | 4.4M | 1.72 | |
| 1life Healthcare | 0.5 | $7.3M | 200k | 36.32 | |
| Akouos | 0.5 | $7.1M | 315k | 22.50 | |
| Avidity Biosciences Ord (RNA) | 0.4 | $6.6M | 235k | 28.26 | |
| Retrophin | 0.3 | $5.1M | 250k | 20.41 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.3 | $4.3M | 100k | 42.56 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.2 | $3.7M | 458k | 8.08 | |
| Fusion Pharmaceuticals (FUSN) | 0.2 | $2.9M | 165k | 17.47 | |
| Zogenix Com New | 0.2 | $2.6M | 98k | 27.01 | |
| Progenity | 0.1 | $2.1M | 239k | 9.00 |
